Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c+ Expression in Tumor.

Isabelle MagalhaesJosefin FernebroSulaf Abd OwnDaria GlaessgenSara CorvignoMats RembergerJonas MattssonHanna Dahlstrand

Published in: Advances in therapy (2020)

Our results show that MSLN expression does not correlate with clinical outcome. The impact of the correlation between MSLN and CD11c+ cells on immunotherapy outcome should be further explored.

Keyphrases

high grade
poor prognosis
binding protein
low grade
induced apoptosis
cell proliferation
signaling pathway